Protecting two lives: new study tests TB prevention safety for pregnant people with HIV
NCT ID NCT05122026
Summary
This study aims to find the safest way to prevent tuberculosis (TB) in pregnant people living with HIV. Researchers are comparing two different dosing schedules of TB prevention drugs to see how well they work with standard HIV medications and how safe they are for both the pregnant person and the baby. The goal is to gather information to help protect this vulnerable group from TB infection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FAMily Centre for Research with Ubuntu (FAMCRU)
Cape Town, Cape Town, 7505, South Africa
-
Peri Natal HIV Research Unit - Klerksdorp Tshepong Hospital
Klerksdorp, North West, 2571, South Africa
-
The Aurum Institute: Tembisa Clinical Research Centre
Tembisa, Gauteng, 1632, South Africa
Conditions
Explore the condition pages connected to this study.